Perceptive Advisors LLC Astria Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $3 Billion
- Q4 2024
A detailed history of Perceptive Advisors LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 6,485,420 shares of ATXS stock, worth $44.2 Million. This represents 1.91% of its overall portfolio holdings.
Number of Shares
6,485,420
Previous 6,485,420
-0.0%
Holding current value
$44.2 Million
Previous $71.4 Million
19.98%
% of portfolio
1.91%
Previous 1.87%
Shares
6 transactions
Others Institutions Holding ATXS
# of Institutions
115Shares Held
50.3MCall Options Held
75KPut Options Held
6.2K-
Ra Capital Management, L.P. Boston, MA5.11MShares$34.8 Million0.73% of portfolio
-
Vestal Point Capital, LP New York, NY4.18MShares$28.5 Million2.22% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$24.2 Million6.29% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$24 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.87MShares$19.6 Million4.34% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $103M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...